Literature DB >> 30988574

Psychiatric Disorders and Quality of Life in Egyptian Patients with Chronic Immune Thrombocytopenic Purpura: A Single Center Study.

Sohier Yahia1, Yahya Wahba1, Abdel-Hady El-Gilany2, Suzy Abdelmabood1, Mohamed Adel El-Hadidy3, Ahmad Darwish1, Ahmed K Mansour1.   

Abstract

The impact of chronic immune thrombocytopenic purpura (ITP) on the psychological health and quality of life is evident among children and adolescents. We aimed to describe psychological disorders and assess quality of life in children with chronic ITP and compared their results with their healthy peers. A cross-sectional comparative study was carried out in a tertiary care university-affiliated hospital during a period from November, 2015 till April, 2018. We enrolled 119 children with chronic ITP and compared with 220 healthy peers. Relevant demographic and clinical data were collected and statistically analyzed. Quality of life for both patients and control groups was measured using pediatric quality of life inventory version 4 (Arabic one). Also psychiatric evaluation of both groups was done using Arabic version of Mini-International Neuropsychiatric Interview for Children (Mini-KID). Majority of patients (90.7%) exhibited mucocutaneous bleeding. Most of patients (61.3%) did not need any definitive treatment for chronic ITP while 38.6% received second line therapy. About one-third of the patients needed rescue medications to control active bleeding. The scores of all sub-scales of Peds QL 4.0 were significantly decreased among patients group when compared to their healthy peers (P < 0.001). General anxiety disorder and oppositional defiant disorders were the commonest psychiatric disorders among children with chronic ITP. Quality of life in children with chronic ITP is markedly impaired with occurrence of a variable spectrum of psychiatric disorders among the studied patients.

Entities:  

Keywords:  Children; Immune thrombocytopenic purpura; Psychiatry; Quality of life

Year:  2018        PMID: 30988574      PMCID: PMC6439116          DOI: 10.1007/s12288-018-1031-0

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  25 in total

Review 1.  Immune thrombocytopenic purpura.

Authors:  Douglas B Cines; Victor S Blanchette
Journal:  N Engl J Med       Date:  2002-03-28       Impact factor: 91.245

2.  Thrombocytopenia during childhood: what the pediatrician needs to know.

Authors:  George R Buchanan
Journal:  Pediatr Rev       Date:  2005-11

Review 3.  Management of patients with refractory immune thrombocytopenic purpura.

Authors:  J N George
Journal:  J Thromb Haemost       Date:  2006-08       Impact factor: 5.824

4.  Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura.

Authors:  Cindy E Neunert; George R Buchanan; Victor Blanchette; Dorothy Barnard; Nancy L Young; Christine Curtis; Robert J Klaassen
Journal:  Pediatr Blood Cancer       Date:  2009-10       Impact factor: 3.167

5.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Authors:  Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George
Journal:  Blood       Date:  2008-11-12       Impact factor: 22.113

Review 6.  Adverse psychological effects of corticosteroids in children and adolescents.

Authors:  F A Stuart; T Y Segal; S Keady
Journal:  Arch Dis Child       Date:  2005-05       Impact factor: 3.791

7.  The PedsQL: measurement model for the pediatric quality of life inventory.

Authors:  J W Varni; M Seid; C A Rode
Journal:  Med Care       Date:  1999-02       Impact factor: 2.983

8.  Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura.

Authors:  Cindy E Neunert; George R Buchanan; Paul Imbach; Paula H B Bolton-Maggs; Carolyn M Bennett; Ellis J Neufeld; Sara K Vesely; Leah Adix; Victor S Blanchette; Thomas Kühne
Journal:  Blood       Date:  2008-08-12       Impact factor: 22.113

9.  Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura.

Authors:  Robert McMillan; James B Bussel; James N George; Deepa Lalla; Janet L Nichol
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047

10.  Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective.

Authors:  Susan D Mathias; Sue K Gao; Kimberly L Miller; David Cella; Claire Snyder; Ralph Turner; Albert Wu; James B Bussel; James N George; Robert McMillan; Diane Kholos Wysocki; Janet L Nichol
Journal:  Health Qual Life Outcomes       Date:  2008-02-08       Impact factor: 3.186

View more
  1 in total

1.  Risk Factors and Psychological Analysis of Chronic Immune Thrombocytopenia in Children.

Authors:  Ying Sun; Sili Long; Wenjun Liu
Journal:  Int J Gen Med       Date:  2020-12-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.